HUP0103403A3 - C11 oxymyl and hydroxylamino prostaglandins useful as fp agonists - Google Patents

C11 oxymyl and hydroxylamino prostaglandins useful as fp agonists

Info

Publication number
HUP0103403A3
HUP0103403A3 HU0103403A HUP0103403A HUP0103403A3 HU P0103403 A3 HUP0103403 A3 HU P0103403A3 HU 0103403 A HU0103403 A HU 0103403A HU P0103403 A HUP0103403 A HU P0103403A HU P0103403 A3 HUP0103403 A3 HU P0103403A3
Authority
HU
Hungary
Prior art keywords
oxymyl
agonists
hydroxylamino
prostaglandins useful
useful
Prior art date
Application number
HU0103403A
Other languages
English (en)
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of HUP0103403A2 publication Critical patent/HUP0103403A2/hu
Publication of HUP0103403A3 publication Critical patent/HUP0103403A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU0103403A 1998-03-31 1999-03-22 C11 oxymyl and hydroxylamino prostaglandins useful as fp agonists HUP0103403A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8021698P 1998-03-31 1998-03-31
PCT/IB1999/000480 WO1999050242A1 (en) 1998-03-31 1999-03-22 C11 oxymyl and hydroxylamino prostaglandins useful as fp agonists

Publications (2)

Publication Number Publication Date
HUP0103403A2 HUP0103403A2 (hu) 2002-01-28
HUP0103403A3 true HUP0103403A3 (en) 2002-12-28

Family

ID=22155990

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0103403A HUP0103403A3 (en) 1998-03-31 1999-03-22 C11 oxymyl and hydroxylamino prostaglandins useful as fp agonists

Country Status (21)

Country Link
EP (1) EP1066254B1 (hu)
JP (1) JP2002509916A (hu)
KR (1) KR20010042285A (hu)
CN (1) CN1295559A (hu)
AR (1) AR018590A1 (hu)
AT (1) ATE296284T1 (hu)
AU (1) AU749540B2 (hu)
BR (1) BR9909268A (hu)
CA (1) CA2324590C (hu)
DE (1) DE69925475T2 (hu)
ES (1) ES2244208T3 (hu)
HU (1) HUP0103403A3 (hu)
IL (1) IL138447A0 (hu)
NO (1) NO20004903L (hu)
NZ (1) NZ506855A (hu)
PE (1) PE20000351A1 (hu)
PL (1) PL343125A1 (hu)
SK (1) SK14722000A3 (hu)
TR (1) TR200002795T2 (hu)
WO (1) WO1999050242A1 (hu)
ZA (1) ZA992394B (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1159266B1 (en) 1999-03-05 2004-11-03 Duke University C-16 unsaturated fp-selective prostaglandins analogs
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
KR100437873B1 (ko) * 2001-05-08 2004-06-26 연성정밀화학(주) 프로스타글란딘 유도체의 제조방법 및 그의 입체특이적출발물질
EP1812017A2 (en) 2004-10-21 2007-08-01 Duke University Ophthamological drugs
MX2009004904A (es) * 2006-11-09 2009-05-19 Bausch & Lomb Sintesis de estereoisomeros seleccionados de ciertos alcoholes sustituidos.
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
CN102101835B (zh) * 2009-12-16 2015-07-22 武汉启瑞药业有限公司 前列腺素衍生物及其中间体的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3538120A (en) * 1967-05-22 1970-11-03 Ciba Geigy Corp Cyclopentyl-alkanoic acids
US3798275A (en) * 1972-04-05 1974-03-19 Ciba Geigy Corp Etherified mercapto-methoxyamines

Also Published As

Publication number Publication date
CA2324590C (en) 2006-06-13
PE20000351A1 (es) 2000-06-22
WO1999050242A1 (en) 1999-10-07
AU749540B2 (en) 2002-06-27
NO20004903D0 (no) 2000-09-29
ZA992394B (en) 1999-09-30
AU3270299A (en) 1999-10-18
KR20010042285A (ko) 2001-05-25
ATE296284T1 (de) 2005-06-15
IL138447A0 (en) 2001-10-31
CA2324590A1 (en) 1999-10-07
EP1066254A1 (en) 2001-01-10
PL343125A1 (en) 2001-07-30
NO20004903L (no) 2000-11-29
CN1295559A (zh) 2001-05-16
BR9909268A (pt) 2001-09-04
EP1066254B1 (en) 2005-05-25
AR018590A1 (es) 2001-11-28
TR200002795T2 (tr) 2001-01-22
DE69925475T2 (de) 2005-11-17
ES2244208T3 (es) 2005-12-01
HUP0103403A2 (hu) 2002-01-28
DE69925475D1 (de) 2005-06-30
NZ506855A (en) 2003-02-28
JP2002509916A (ja) 2002-04-02
SK14722000A3 (sk) 2001-07-10

Similar Documents

Publication Publication Date Title
ZA991951B (en) Compound and its use.
EP0956018A4 (en) IMIDAZOLE COMPOUNDS, COMPOSITIONS CONTAINING THEM AND THEIR USE
AU9686398A (en) Metal-fly ash composites and low pressure infiltration methods for making the same
ZA9710577B (en) 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists.
GB9817235D0 (en) Compound,composition and use
ZA992393B (en) C11oxymyl and hydroxylamino prostaglandins useful as FP agonists.
GB9817236D0 (en) Compound,composition and use
IL138447A0 (en) C11 oxymyl and hydroxylamino prostaglandins useful as fp agonists
GB9718876D0 (en) Compound,composition and use
ZA9710579B (en) 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists.
GB9803232D0 (en) Compound composition and use
HK1042304A1 (en) Organophosphorous compounds and the use thereof
GB2344351B (en) Synthetic fire logs
GB9817238D0 (en) Compound,composition and use
GB9723859D0 (en) Compound,composition and use
ZA9710574B (en) 2-imidazolinylaminobenzothiazole compounds useful as alpha-2 adrenoceptor agonists.
ZA9710576B (en) 2-imidazolinylaminoindazole compounds useful as alpha-2-adrenoceptor agonists
GB9426290D0 (en) Composition,compound and use
GB9808637D0 (en) Preservative
GB9723856D0 (en) Compound,composition and use
GB9723858D0 (en) Compound,composition and use
GB2334477B (en) Log or journal
GB9723855D0 (en) Compound, composition and use
GB9422162D0 (en) Composition, compound and use
GB9426293D0 (en) Composition,compound and use